Chart 1: The black arrow signals the number of patients that dropped-out of the trial before one month of treatment. The average of total of days under treatment with nimodipine per patient according to the administered dose they were allocated to; T-Test (arm A vs. B) [83.7 ± 20.8 (49-90) vs. 76.5 ± 27.9 (51-90)], p= 0.35. Retention rate by groups was 76.9 vs. 92.3 (p=0.30).